
Amy Abernethy, the number two official at the Food and Drug Administration, plans to depart the agency in mid-to-late April.
The announcement was made in a memo from Janet Woodcock, the acting commissioner of the Food and Drug Administration, who called Abernethy “a talented and inspiring leader” and said she takes heart in Abernethy’s “enduring accomplishments.”